Akoya Biosciences (NASDAQ: AKYA)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-09 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.440 | -0.0500 | ||||
REV | 14.930M | 16.894M | 1.964M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Akoya Biosciences (NASDAQ: AKYA) through any online brokerage.
Other companies in Akoya Biosciences’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), Olink Holding (NASDAQ:OLK), Quanterix (NASDAQ:QTRX) and SomaLogic (NASDAQ:SLGC).
The latest price target for Akoya Biosciences (NASDAQ: AKYA) was reported by BTIG on Wednesday, June 22, 2022. The analyst firm set a price target for 16.00 expecting AKYA to rise to within 12 months (a possible 24.80% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Akoya Biosciences (NASDAQ: AKYA) is $12.82 last updated June 29, 2022, 8:00 PM UTC.
There are no upcoming dividends for Akoya Biosciences.
Akoya Biosciences’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for Akoya Biosciences.
Akoya Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.